Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 2/20 | 0.31 |
| ▸ | PPARA | Q07869 | 2/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.30 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22780006 | 0.92 | CHRNB4 (0.32) | CHRNB4CHRNA3CHRNA7MCL1ACMSD | |
| SCHEMBL23614111 | 0.92 | CHRNB4 (0.32) | CHRNB4CHRNA3CHRNA7MCL1ACMSD | |
| SCHEMBL23614712 | 0.91 | CA12 (0.34) | CHRNB4CHRNA3CHRNA7PPARGPPARA | |
| SCHEMBL23614420 | 0.90 | CA12 (0.33) | CHRNB4CHRNA3CHRNA7CA12CA1 | |
| SCHEMBL23614708 | 0.89 | CA12 (0.36) | CHRNB4CHRNA3PPARGPPARAMCL1 | |
| SCHEMBL23621470 | 0.88 | CHRNB4 (0.32) | CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL23614451 | 0.88 | — | — | |
| SCHEMBL23621764 | 0.87 | MCL1 (0.33) | CHRNB4CHRNA3CHRNA7MCL1ACMSD | |
| SCHEMBL25451921 | 0.87 | MCL1 (0.33) | CHRNB4CHRNA3CHRNA7MCL1ACMSD | |
| SCHEMBL25452284 | 0.87 | MCL1 (0.33) | CHRNB4CHRNA3CHRNA7MCL1ACMSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-28 | — | — | US | disclosed |
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-28 | — | — | US | disclosed |
| US-20220081408-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | SHAANXI LTMS OPTOELECTRONICS MATERIAL CO. LTD. (CN) | 2022-03-17 | — | — | US | disclosed |
| US-11203584-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2021-12-21 | — | — | US | disclosed |
| US-20210206741-A1 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2021-07-08 | — | — | US | disclosed |
| EP-3845522-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | Shaanxi Lighte Optoelectronics Material Co., Ltd. (CN) | 2021-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210206741-A1 | Nitrogen-containing compound, electronic element and electronic device | NOS1, PRMT1, MNS1 | CHRNB4 2593/4885CHRNA3 3287/4885CHRNA7 3070/4885 |
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | NOS1, PRMT1, MNS1 | CHRNB4 2593/4885CHRNA3 3287/4885CHRNA7 3070/4885 |
| US-20220081408-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | NOS1, PRMT1, MNS1 | CHRNB4 2593/4885CHRNA3 3287/4885CHRNA7 3070/4885 |
| US-11203584-B2 | Nitrogen-containing compound, electronic element and electronic device | NOS1, PRMT1, MNS1 | CHRNB4 2593/4885CHRNA3 3287/4885CHRNA7 3070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.